March 8, 2011 – A third-generation bare-metal stent system has received the CE Mark in Europe. Boston Scientific’s Omega platinum chromium coronary stent system is intended to provide interventional cardiologists with improved acute performance in treating patients with coronary artery disease.

March 7, 2011 – Massachusetts General Hospital (MGH) has granted an exclusive license to Santaris Pharma A/S for intellectual property related to the regulation of microRNA for the treatment of cardiovascular disorders.

March 7, 2011 – A new digital intra-vascular ultrasound (IVUS) catheter has been cleared in Japan. The Eagle Eye Platinum digital IVUS catheter, from Volcano, was introduced at the Percutaneous Coronary Intervention (PCI) Live Demonstration Course in Kurashiki.

March 7, 2011 – Last week Medtronic Inc. cancelled its five contracts with Novation LLC, one of the largest U.S. group purchasing organizations (GPOs), which previously represented $2 billion. The contracts included reduced price, large group purchases of cardiovascular and orthopedic devices.

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent litigation case with AGA Medical-St. Jude Medical.

Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a definitive merger agreement announced on Jan. 19, 2011.

March 4, 2011 – According to a retrospective sub-study of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), there is no evidence that implantable cardioverter defibrillator (ICD) benefit varies with time from myocardial infarction (MI) to device implantation. Accordingly, single lead ICD benefit is not restricted to patients with a remote MI (more than 18 months).